Wei-Yih Chiu Selected Research

Wei-Yih Chiu Research Topics

Disease

5	Osteonecrosis (Kienbock's Disease) 01/2022 - 04/2013
3	Neoplasms (Cancer) 09/2023 - 01/2012
3	Graves Disease (Basedow Disease) 08/2018 - 05/2007
2	Hypophosphatemia 09/2023 - 12/2014
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 04/2016 - 01/2016
2	Osteoporosis 08/2014 - 04/2013
2	Thyroid Neoplasms (Thyroid Cancer) 01/2012 - 01/2012
1	Osteomalacia 09/2023
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Anemia 01/2022
1	Drug-Related Side Effects and Adverse Reactions 08/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 08/2018
1	Hyperthyroidism 08/2018
1	Bisphosphonate-Associated Osteonecrosis of the Jaw 01/2018
1	Agranulocytosis (Granulocytopenia) 07/2015
1	Ovarian Neoplasms (Ovarian Cancer) 12/2014
1	Low Back Pain (Lumbago) 12/2014
1	Familial Hypophosphatemia (Phosphate Diabetes) 12/2014
1	Rheumatoid Arthritis 08/2014
1	Compression Fractures (Compression Fracture) 04/2013
1	Femoral Fractures (Femoral Fracture) 04/2013
1	Obesity 01/2012
1	Vitamin D Deficiency 01/2012
1	Papillary Thyroid Cancer 01/2012
1	Insulin Resistance 01/2012
1	Deafness (Deaf Mutism) 11/2006
1	Hypoparathyroidism 11/2006
1	Thyrotoxicosis 01/2004
1	Deglutition Disorders (Dysphagia) 01/2004

Drug/Important Bio-Agent (IBA)

3	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2018 - 04/2013
2	Bone Density Conservation AgentsIBA 01/2022 - 08/2021
2	Antithyroid Agents (Antithyroid Drugs)IBA 08/2018 - 07/2015
2	Diphosphonates (Bisphosphonates)IBA 01/2018 - 04/2013
2	Moxifloxacin (Avelox)FDA Link 04/2016 - 01/2016
2	Ofloxacin (Ofloxacine)FDA LinkGeneric 04/2016 - 01/2016
1	Fibroblast Growth Factor 1 (FGF-1)IBA 09/2023
1	pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate (PMTS)IBA 09/2023
1	Fibroblast Growth Factor-23IBA 09/2023
1	RNA (Ribonucleic Acid)IBA 09/2023
1	CollagenIBA 01/2022
1	Denosumab FDA Link 01/2022
1	Zoledronic Acid (Zometa)FDA Link 08/2021
1	Methimazole (Thiamazole)FDA LinkGeneric 08/2018
1	CarbimazoleIBA 08/2018
1	Long-Acting Thyroid Stimulator (LATS)IBA 08/2018
1	TESIBA 01/2018
1	FluoroquinolonesIBA 01/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 07/2015
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2014
1	Alkaline PhosphataseIBA 12/2014
1	Phosphates (Orthophosphate)IBA 12/2014
1	Raloxifene Hydrochloride (Evista)FDA Link 08/2014
1	Insulin (Novolin)FDA Link 01/2012
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2012
1	Glucose (Dextrose)FDA LinkGeneric 01/2012
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2012
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2012
1	Triglycerides (Triacylglycerol)IBA 01/2012
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2012
1	Exenatide (Byetta)FDA Link 01/2012
1	Liraglutide FDA Link 01/2012
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2012
1	AntigensIBA 05/2007
1	ZincIBA 11/2006
1	Proteins (Proteins, Gene)FDA Link 11/2006
1	Codon (Codons)IBA 11/2006

Therapy/Procedure

2	Therapeutics 08/2021 - 08/2014
2	Aftercare (After-Treatment) 12/2014 - 01/2004
1	Tooth Extraction (Tooth Extractions) 01/2018
1	Drug Therapy (Chemotherapy) 12/2014
1	Duration of Therapy 08/2014